Abstract
The case is reported of an infant presenting paroxysmal dystonia during cisapride theraphy. We suggest that this drug, a substituted benzamide, probably interfered with the age-related modification of striatal neurotransmitters, provoking extrapyramidal symptoms. Considering the widespread use of cisapride in early infancy for the treatment of gastrointestinal disorders, attention must be drawn to this possible side effect.
Sommario
Presentiamo il caso di una bambina di 5 mesi, trattata sin dalla nascita con cisapride per la prevenzione di reflusso gastroesofageo, in quanto affetta da atresia congenita dell'esofago corretta chirurgicamente in 1° giornata di vita. Dal 3° mese la bambina presentò, con frequenza ingravescente, distonie accessuali non più verificatesi dalla sospensione del trattamento farmacologico.
La precocità di comparsa della fenomenologia accessuale, la relazione temporale tra cessazione della stessa e sospensione del farmaco, nonché alcune caratteristiche semeiologiche sottolineate nel lavoro, portano ad attribuire alla cisapride un ruolo causale.
I processi di sviluppo all'interno dello striato propri di questa età della vita, che comportano rapidi rimaneggiamenti strutturali e di equilibrio funzionale tra i principali neurotrasmettitori, hanno sicuramente rappresentato una situazione favorente nei confronti di un disturbo extrapiramidale transitorio.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Angelini L., Nardocci N., Rumi V.:Transient dystonic symptoms in infancy: a possible correlation with developmental processes in the striatum. Basal Ganglia 89 3rd Triennal Meeting Capo Boi 10–13 giugno 1989, Abstract Book, pp. 7.
Angelini L., Rumi V., Lamperti E., Nardocci N.:Transient paroxysmal dystonia in infancy. Neuropediatrics 19: 171–174, 1988.
Benloucif S., Keegan M.J., Galloway M.P.:Serotonin-facilitated dopamine release in vivo: pharmacological characterization. J. Pharmacol. Exp. Ther. 265: 373–377, 1993.
Bockaert J., Fozard J.R., Dumulis A., Clarke D.E.:The 5-HT 4 receptor: a place in the sun. Trends Pharmacol. Sci. 13: 141–145, 1992.
Casteels-Van Daele M., Van De Schueren P., Zimmermann A., Van Den Bon P.:Dystonic reactions in children caused by metoclopramide. Arch. Dis. Child. 45: 130–133, 1970.
Davson H.:The blood brain barrier. In: Boume G.H. (Eds.), The structure and function of nervous tissue. New York and London: Academic Press, vol. 4, pp. 321–445, 1972.
Dumulis A., Sebben M., Bockaert J.:The gastrointestinal prokinetic benzamide derivates are agonist at the non-classical 5-HT receptor (5-HT 4)positively coupled to adenylate cyclase in neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 340: 403–410, 1989.
Emerit M.B., Riad M., Fataccini C.M., Hamon M.:Characteristics of [14C] Guanidinium accumulation in NG 108-15 cells exposed to serotonin 5-HT3 receptor ligands and substance. P. J. Neurochem. 60: 2059–2067, 1993.
Fehr H.F.:Risk factors, co-medication, and concomitant diseases: their influence on the outcome of theraphy with cisapride. Scand. J. Gastroenterol. Suppl. 195: 40–46, 1993.
Flynn D.L., Zabrowski D.L., Becker D.P. et al.:SC-53116: the first selective agonist at the newly identified serotonine 5-HT 4 receptor subtype. J. Med. Chem. 35: 1489–1491, 1992.
Graybiel A.M., Newman-Gage H.:Ontogeny of dopaminergic and cholinergic systems in the basal ganglia. In: L. Angelini, G. Lanzi, U. Balottin, N. Nardocci (Eds.), Extrapyramidal Disorders in Childhood. Amsterdam Excerpta Medica pp. 1–10, 1987.
Kilpatrick G.J., Rogers H.:5-HT 3 receptors. In: P.M. Vanhoutte et al. (Eds.), Serotonin from cell biology to pharmacology and therapeutics. Netherlands, Kluver Academic Publishers and Fondazione Giovanni Lorenzini pp. 99–106, 1993.
Kinsbourne M.:Hiatus hernia with contorsion of the neck. Lancet 1: 1058, 1964.
Megens A.A., Awouters F.H., Niemegeers C.J.:General pharmacology of the four gastrointestinal motility stimulants bethanechol, metcolopramide, trimebutine and cisapride. Arzneimittelforschung 41: 631–634, 1991.
Michelis M., Monbaliu J., Henriks R. et al.:Pharmacokinetics and tissue distribution of the new gastrokinetic agent cisapride in rat, rabbit and dog. Arzneimittelforschung 37: 1159–1167, 1987.
Semenova T.P., Ticku M.K.:Effects of 5-HT receptor antagonists on seizure susceptibility and locomotor activity in DBA/2 mice. Brain Res. 588: 229–236, 1992.
Steward L.J., Bames N.M.:The 5-HT 4 receptor agonists renzapride and (S)-zacopride stimulate dopamine release from rat striatal slices. Proc. British Pharmacol. Soc. 14–16 September, 1993; P9.
Waeber C., Sebben M., Grossman C., Javoy-Agid F., Bockaert J., Dumulis A.: [3 H]-GR113808 labels 5-HT 4 receptors in the human and guinea-pig brain. Neuroreport 4: 1239–1242, 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Angelini, L., Zorzi, G., Rumi, V. et al. Transient paroxysmal dystonia in an infant possibly induced by cisapride. Ital J Neuro Sci 17, 157–159 (1996). https://doi.org/10.1007/BF02000848
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02000848